The average daily intake in the West is 15 mcg per day, far below the level required to carboxylate proteins that lead to osteoporosis, cardiovascular disease, and neurological disease. A 2012 study, which aimed to determine the effective dose of K2, tested a dosing range from 10mcg to 360 mcg. Study authors found that only the two highest dosages (180 and 360 mcg) were sufficient to obtain all the benefits of vitamin K2 and the highest dose was measurably the most beneficial. The 300+ mcg dose would be the most potent dose on the market, and reflects the average consumption of K2 in the Eastern Japanese populations—a dose that has been shown to be very effective in prevention of disease.
Given the fact that nearly everyone in the Western World is subclinically deficient in K2, as was described in a published study, this deficiency has a wide scope of influence on human health and the health and longevity of your patients. Supplementing with the optimum dose is paramount to rescue your patients from years of vitamin K2 deficiency and to reduce their risk of the most common chronic diseases. Supplementation with MegaQuinone, the highest potency vitamin K2 on the market, is an obvious choice!